Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI study. [electronic resource]
Producer: 20120831Description: 529-42 p. digitalISSN:- 1538-7836
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Aryl Hydrocarbon Hydroxylases -- genetics
- Austria
- Blood Platelets -- drug effects
- Cardiovascular Diseases -- blood
- Cell Adhesion Molecules -- blood
- Chi-Square Distribution
- Clopidogrel
- Coronary Artery Disease -- blood
- Cytochrome P-450 CYP2C19
- Female
- Gene Frequency
- Genotype
- Hemorrhage -- chemically induced
- Humans
- Kaplan-Meier Estimate
- Logistic Models
- Male
- Microfilament Proteins -- blood
- Middle Aged
- Multivariate Analysis
- Pharmacogenetics
- Phenotype
- Phosphoproteins -- blood
- Phosphorylation
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- adverse effects
- Platelet Function Tests
- Polymorphism, Genetic
- Predictive Value of Tests
- Prospective Studies
- Risk Assessment
- Risk Factors
- Sensitivity and Specificity
- Thrombosis -- blood
- Ticlopidine -- adverse effects
- Time Factors
- Treatment Outcome
- Vasodilator-Stimulated Phosphoprotein
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.